Iacocca pledges $1 million to the type 1 diabetes cause

NewsGuard 100/100 Score

Lee Iacocca the Chief Executive Officer of Chrysler from 1978 to 1992 has announced the launch of "Join Lee Now," a fundraising initiative to investigate a potential cure for type 1 diabetes. Mr Iacocca has personally pledged $1 million to the cause.

The initiative hopes to raise $11 million to fund a potential cure for type 1 diabetes. The funds raised as part of this initiative will be separate from the giving the Iacocca Foundation currently contributes to diabetes research and will go directly to support the clinical trials investigating this potential cure at Massachusetts General Hospital (MGH).

Diabetes is caused by an alteration in the metabolism of carbohydrates due to a deficiency in production of the hormone insulin by the pancreas. Insulin helps cells use sugar as a fuel and also transforms it into energy.

There are two forms of diabetes: Type 1, or insulin-dependent diabetes, in which a person has to keep track of insulin levels with daily injections, and Type 2, which is not dependent on insulin.

Type 1 diabetes is an autoimmune disease that destroys the insulin-producing cells of the pancreas. Formerly known as insulin-dependent diabetes, it often strikes children and young adults, who must rely on insulin injections or an insulin pump for survival. An estimated 1 million Americans have type 1 diabetes.

Ninety percent of diabetics suffer from Type 2 diabetes, which is also known as "silent diabetes." It usually develops in people over 40, with limited or no symptoms. However, increasing levels of obesity in the population have resulted in Type 2 diabetes appearing more frequently in adolescents and in young adults.

"Since the death of my wife in 1983 from the complications of diabetes, I have been driven to do everything I can to fund diabetes research. Last year, one of the researchers we have supported for over a decade cured type 1 diabetes in mice. I'm not going to wait for the government or the pharmaceutical industry to decide to get the human trials going. We need $11 million for these clinical trials now. I've given the first million and I'm asking the American people to get behind me and give the rest," said Lee Iacocca, Chairman of the Iacocca Foundation.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals altered protein rhythms linked to metabolic disorders in night shift workers